Abivax Announces Closing of $920 Million Public Offering
Abivax closed a public offering of 7,360,000 ADSs, raising aggregate gross proceeds of $920.0 million, which includes the full exercise of the underwriters' option. The estimated net proceeds of approximately $874.1 million, together with existing cash, will fund operations into the fourth quarter of 2029.
Key figures
- Net Proceeds
- $874.1 million
- Deal Value Usd
- $920.0 million
- Shares Offered
- 7360000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.